An official website of the United States government
Number and rate* of newly reported cases† of chronic hepatitis B, by state or jurisdiction — United States, 2022
* Rates per 100,000 population.
† Reported confirmed cases. For case definition, see Chronic Hepatitis B.
N: Not reportable. The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
U: Unavailable. The data were unavailable.
In the United States, chronic hepatitis B is one of the leading causes of cirrhosis and liver cancer. This table displays the numbers and rates of newly reported chronic hepatitis B cases during 2022, by state or jurisdiction. In 2022, chronic hepatitis B was not a reportable condition in four states (Connecticut, Kentucky, Mississippi, and Texas), and cases were unavailable from two states (Arkansas and Hawaii). The highest rate of newly reported chronic hepatitis B was in Rhode Island (33.3 cases per 100,000 population), whereas the lowest rate was in New Hampshire (0.1 cases per 100,000 population). Of note, cases of newly reported chronic hepatitis B do not represent all prevalent hepatitis B virus (HBV) infections, which is not captured in the National Notifiable Diseases Surveillance System (NNDSS).
- Figure 2.1. Number of reported cases and estimated infections of acute hepatitis B — United States, 2015–2022
- Figure 2.2. Rates of reported cases of acute hepatitis B, by state or jurisdiction — United States, 2021–2022
- Figure 2.3. Rates of reported cases of acute hepatitis B, by state or jurisdiction — United States, 2022
- Figure 2.4. Rates of reported cases of acute hepatitis B, by age group — United States, 2007–2022
- Figure 2.5. Rates of reported cases of acute hepatitis B, by sex — United States, 2007–2022
- Figure 2.6. Rates of reported cases of acute hepatitis B, by race/ethnicity — United States, 2007–2022
- Figure 2.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis B — United States, 2022
- Figure 2.8. Rates of deaths with hepatitis B listed as a cause of death among residents, by state or jurisdiction — United States, 2022
- Table 2.1. Numbers and rates of reported cases of acute hepatitis B, by state or jurisdiction — United States, 2018–2022
- Table 2.2. Numbers and rates of reported cases of acute hepatitis B, by demographic characteristics — United States, 2018–2022
- Table 2.3. Reported risk behaviors or exposures among reported cases of acute hepatitis B — United States, 2022
- Table 2.4. Number of newly reported cases of perinatal hepatitis B, by state or jurisdiction — United States, 2022
- Table 2.5. Number and rate of newly reported cases of chronic hepatitis B, by state or jurisdiction — United States, 2022
- Table 2.6. Number and rate of newly reported cases of chronic hepatitis B, by demographic characteristics — United States, 2022
- Table 2.7. Numbers and rates of deaths with hepatitis B listed as a cause of death among residents, by state or jurisdiction — United States, 2018–2022
- Table 2.8. Numbers and rates of deaths with hepatitis B listed as a cause of death among residents, by demographic characteristics — United States, 2018–2022